BeOne Medicines (ONC) Interest Coverage Ratio (2015 - 2026)

BeOne Medicines' (ONC) quarterly Interest Coverage Ratio came in at 7.6 in Q1 2026, up 787.12% year-on-year from 0.86 in Q1 2025, and down 49.52% on a QoQ basis from 15.05 in Q4 2025.

BeOne Medicines (ONC) Interest Coverage Ratio (2015 - 2026) Analysis & Trends

BeOne Medicines (ONC) has 12 years of Interest Coverage Ratio data on file, last reported at 7.6 in Q1 2026.

  • On a quarterly basis, Interest Coverage Ratio rose 787.12% year-over-year to 7.6 in Q1 2026; TTM through Mar 2026 was 9.82, a 287.74% increase from a year earlier, with the FY2025 full-year figure at 0.12, up 173.42% from the prior year.
  • Interest Coverage Ratio for Q1 2026 stood at 7.6, down from 15.05 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for ONC reached as high as 32.72 in Q4 2023 and fell as low as 80.54 in Q2 2022.
  • Historically, Interest Coverage Ratio has averaged 23.07 across 5 years, with a median of 8.4 in 2024.
  • Across the five-year window, Interest Coverage Ratio tumbled 763.55% in 2022 and soared 787.12% in 2026, its largest moves.
  • Year by year, Interest Coverage Ratio stood at 40.81 in 2022, then soared by 180.17% to 32.72 in 2023, then plunged by 115.12% to 4.95 in 2024, then surged by 404.33% to 15.05 in 2025, then slumped by 49.52% to 7.6 in 2026.
  • Per Business Quant data, the three most recent Interest Coverage Ratio figures were 7.6 in Q1 2026, 15.05 in Q4 2025, and 12.89 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 658.42
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -157.58
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 7.60
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 22.72
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -0.38
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 3.88

Historic Data

Download Data
DateValue
Mar 31, 2026 7.60
Dec 31, 2025 15.05
Sep 30, 2025 12.89
Jun 30, 2025 7.29
Mar 31, 2025 0.86
Dec 31, 2024 -4.95
Sep 30, 2024 -8.40
Jun 30, 2024 -8.10
Mar 31, 2024 -21.07
Dec 31, 2023 32.72
Sep 30, 2023 -20.21
Jun 30, 2023 -65.16
Mar 31, 2023 -74.00
Dec 31, 2022 -40.81
Sep 30, 2022 -78.33
Jun 30, 2022 -80.54
Mar 31, 2022 -66.99
Dec 31, 2021 29.01
Sep 30, 2021 -60.76
Jun 30, 2021 -62.26